Positive One-Year Follow-Up Results Revealed in C-GUARDIANS U.S. IDE Clinical Trial of CGuard at LINC 2024
Tuesday, 28 May 2024, 10:04
Key Findings:
The follow-up results of the C-GUARDIANS U.S. IDE Clinical Trial showcase positive outcomes and advancements in the study.
Significance:
This presentation at LINC 2024 demonstrates the efficacy and potential of the CGuard medical device.
Impact:
- Promising results indicate the effectiveness of CGuard in enhancing cardiovascular health.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.